Stock Events

Stock Events

Search...

Acadia Pharmaceuticals (ACAD) Q4 2013 Earnings

6NovConfirmed

Mar 13

May 13

Q3 2013

Q4 2013

-0.12

-0.11

-0.09

-0.08

Details

Expected EPS

N/A

Actual EPS

-0.12

Surprise EPS

-0.12

Surprise Percent

+∞%

Description

Acadia Pharmaceuticals (ACAD) has reported earnings of -0.12 per share for Q4 2013.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.